Alzheimer’s Disease/Dementia News

Positive airway pressure treatment was associated with a lower likelihood of incident Alzheimer’s disease and other types of dementia in older adults with obstructive sleep apnea, researchers reported.

Living in the most disadvantaged neighborhoodss correlated with increased degeneration in Alzheimer’s disease “signature” regions of the brain and cognitive decline, according to the results of a longitudinal study in cognitively healthy adults.

A significant proportion of patients who had COVID-19 experienced neurological and psychiatric morbidity in the 6 months following infection, according to results of a retrospective cohort study published in The Lancet Psychiatry.

Findings from a prospective cohort study of patients with mild traumatic brain injury demonstrated that women were more likely than men to experience persistent cognitive and somatic symptoms related to the injury.

Dual sensory impairment in vision and hearing increased the rate of dementia and cognitive decline over the course of a 6-year follow-up period, according to findings from a community-based elderly cohort study published in Neurology.

Acadia Pharmaceuticals has received a complete response letter from the FDA stating that the administration cannot approve a supplemental new drug application for pimavanserin.

Patients of a racial or ethnic minority group experienced a lower chance of receiving an earlier diagnosis of dementia or a comprehensive evaluation compared to white patients, according to findings published in JAMA Neurology.

Older adults recently diagnosed with dementia or mild cognitive impairment were at increased risk for suicide attempt, according to results of a nationwide cohort study published in JAMA Psychiatry.

Variances in amyloid positivity across nine subgroups of patients, who were classified according to cognitive states and white matter hyperintensity levels, suggested Alzheimer’s and cerebral small vessel diseases exist on a continuum.

History of head injury correlated with a greater risk for dementia in a dose-dependent manner, according to results from a community-based cohort study with 25 years of follow-up published in Alzheimer’s & Dementia.